Could a simple pill save dialysis lifelines? new trial investigates
NCT ID NCT07559942
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a short course of the blood thinner apixaban can help new dialysis access points (arteriovenous fistulas) mature properly in people with end-stage kidney disease. About 190 adults will receive either apixaban or a placebo around the time of fistula creation surgery. The goal is to see if the drug reduces early blockage and improves the chance the fistula will be usable for dialysis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTERIOVENOUS FISTULA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Combined Military Hospital, Lahore
RECRUITINGLahore, Punjab Province, 54300, Pakistan
Contact Email: •••••@•••••
Contact